Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;28(2):91-98.
doi: 10.1097/MOL.0000000000000394.

The walking dead: macrophage inflammation and death in atherosclerosis

Affiliations
Review

The walking dead: macrophage inflammation and death in atherosclerosis

Mary M Kavurma et al. Curr Opin Lipidol. 2017 Apr.

Abstract

Purpose of review: To highlight recent studies that describe novel inflammatory and signaling mechanisms that regulate macrophage death in atherosclerosis.

Recent findings: Macrophages contribute to all stages of atherosclerosis. The traditional dogma states that in homeostatic conditions, macrophages undergo apoptosis and are efficiently phagocytosed to be cleared by a process called efferocytosis. In advanced atherosclerosis, however, defective efferocytosis results in secondary necrosis of these uncleared apoptotic cells, which ultimately contributes to the formation of the characteristic necrotic core and the vulnerable plaque. Here, we outline the different types of lesional macrophage death: apoptosis, autophagic and the newly defined necroptosis (i.e. a type of programmed necrosis). Recent discoveries demonstrate that macrophage necroptosis directly contributes to necrotic core formation and plaque instability. Further, promoting the resolution of inflammation using preresolving mediators has been shown to enhance efferocytosis and decrease plaque vulnerability. Finally, the canonical 'don't eat me' signal CD47 has recently been described as playing an important role in atherosclerotic lesion progression by impairing efficient efferocytosis. Although we have made significant strides in improving our understanding of cell death and clearance mechanisms in atherosclerosis, there still remains unanswered questions as to how these pathways can be harnessed using therapeutics to promote lesion regression and disease stability.

Summary: Improving our understanding of the mechanisms that regulate macrophage death in atherosclerosis, in particular apoptosis, necroptosis and efferocytosis, will provide novel therapeutic opportunities to resolve atherosclerosis and promote plaque stability.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest:

The authors declare that no conflict of interest exists.

Figures

Figure 1
Figure 1. Macrophage Apoptosis, Autophagy and Necroptosis in Atherosclerosis
In early lesions, modified lipoproteins (e.g. oxLDL) act as inflammatory stimuli within the vessel wall to recruit circulating monocytes, which avidly phagocytose these modified lipids to become macrophage foam cells. These cells then eventually undergo 3 main types of cell death within the vessel wall: apoptosis, autophagy-related cell death and necroptosis. Macrophages that undergo apoptosis can be efficiently efferocytosed to be cleared by other macrophages (purple), whereas necroptotic macrophages are ineffectively efferocytosed (grey), resulting in the accumulation of inflammatory stimuli within the intima that propagates atherosclerosis. Together, both increased cell death and defective efferocytosis ultimately results in the formation of the necrotic core, which is the hallmark of a rupture-prone, vulnerable plaque.

Similar articles

Cited by

References

    1. Moore KJ, Tabas I. Macrophages in the Pathogenesis of Atherosclerosis. Cell. 2011;145:341–355. - PMC - PubMed
    1. Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J. Intern. Med. 2015;278:483–493. - PMC - PubMed
    1. Sakakura K, Nakano M, Otsuka F, Ladich E, Kolodgie FD, Virmani R. Pathophysiology of atherosclerosis plaque progression. Heart Lung Circ. 2013;22:399–411. - PubMed
    1. Yahagi K, Kolodgie FD, Otsuka F, Finn AV, Davis HR, Joner M, et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol. 2016;13:79–98. A comprehensive review of observational pathology of various stages of human atherosclerotic diseases. - PubMed
    1. Shankman LS, Gomez D, Cherepanova OA, Salmon M, Alencar GF, Haskins RM, et al. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat. Med. 2015;21:628–637. A key study using lineage tracing technology re-defined our understanding of the cells involved in atherosclerotic lesions: SMCs can transform into macrophage-like cells in mice. - PMC - PubMed